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Compensation has been widely applied to explain neuroimaging findings in
neuropsychiatric patients. Functional compensation is often invoked when patients
display equal performance and increased neural activity in comparison to healthy
controls. According to the compensatory hypothesis increased activity allows the brain
to maintain cognitive performance despite underlying neuropathological changes. Due
to methodological and pathology-related issues, however, the functional relevance of
the increased activity and the specific brain regions involved in the compensatory
response remain unclear. An experimental approach that allows a transient induction of
compensatory responses in the healthy brain could help to overcome these issues. To
this end we used the non-selective beta-blocker propranolol to pharmacologically induce
sub-optimal noradrenergic signaling in healthy participants. In two independent functional
MRI (fMRI) experiments participants received either placebo or propranolol before
they underwent a cognitive challenge (Experiment 1: working memory; Experiment 2:
emotional learning: Pavlovian fear conditioning). In Experiment 1 propranolol had no
effects on working memory performance, but evoked stronger activity in the left
inferior frontal gyrus (IFG). In Experiment 2 propranolol produced no effects on
emotional memory formation, but evoked stronger activity in the right IFG. The present
finding that sub-optimal beta-adrenergic signaling did not disrupt performance and
concomitantly increased IFG activity is consistent with, and extends, current perspectives
on functional compensation. Together, our findings suggest that under conditions of
impaired noradrenergic signaling, heightened activity in brain regions located within the
cognitive control network, particularly the IFG, may reflect compensatory operations
subserving the maintenance of behavioral performance.
Keywords: compensation, fMRI, noradrenaline, propranolol, working memory, emotional learning, inferior frontal
cortex, cognitive control
INTRODUCTION
The theoretical construct “neural compensation” is widely
applied to explain functional neuroimaging results in neuropsy-
chiatric patients. Functional compensation is often invoked when
populations with presumed pathological or age-related brain
changes display intact cognitive performance and concomitantly
enhanced neural activity in comparison to healthy controls
(Maruishi et al., 2007; Schwindt and Black, 2009; Erk et al.,
2011; Koester et al., 2013). According to current concepts of
neural compensation, increased activity is thought to reflect
compensatory operations which subserve the maintenance of
cognitive functions despite neuropathological changes (Park and
Reuter-Lorenz, 2009; Grady, 2012). Neural compensation has
been implicated in various neuropsychiatric disorders, including
Alzheimer’s disease (AD), brain damage, affective illness, or drug
addiction (Erk et al., 2011; Etkin and Schatzberg, 2011; Becker
et al., 2012; Koester et al., 2013). Most frequently compensatory
mechanisms have been observed in AD patients. Extensive degen-
eration of the locus coeruleus-norephineprine (LC-NE) system is
universal in this disease [for an overview see (Chalermpalanupap
et al., 2013)] and altered LC-NE functioning is among the ear-
liest pathologies of AD (Mann et al., 1980; Haglund et al.,
2006), which even can be detected during early prodromal stages
(Grudzien et al., 2007; Braak and Del Tredici, 2011). LC-NE
degeneration has been closely linked to cognitive decline in AD
(Weinshenker, 2008) and animal models of AD have revealed
compelling evidence that elevated NE signaling could amelio-
rate cognitive deficits in AD. Despite the continued attention
the compensatory concept has received in the context of neu-
ropathological diseases, particularly AD, important issues still
remain unsolved. Depending on the cognitive function and the
specific clinical population under investigation, increased activ-
ity in several brain regions has been attributed to compensatory
mechanisms. Recent meta-analytic data from AD patients suggest
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that prefrontal regions, particularly ventrolateral and dorsolat-
eral subdivisions of the prefrontal cortex, are critically involved
in compensation (Schwindt and Black, 2009). However, several
pathology-related issues, such as confounding effects of task per-
formance (Gould et al., 2005, 2006), cortical atrophy (Johnson
et al., 2000) and lower baseline activity in patients (Lustig et al.,
2003; Greicius et al., 2004) might have influenced the results of
these analyses. It is therefore mandatory to study neural com-
pensation in the absence of pathological brain changes. Given the
association between decreased LC-NE signaling in AD, one exper-
imental strategy to transiently model compensatory responses in
the healthy brain might be the pharmacological inhibition of NE
signaling.
Biosynthesis of the neurotransmitter norepinephrine (NE,
noradrenaline) depends on the nutritional availability of its
amino acid precursor tyrosine (Fernstrom and Fernstrom, 1994),
and NE homeostasis is crucial for a variety of brain regions
receiving noradrenergic innervation, including the prefrontal
cortex and amygdala (Robbins and Arnsten, 2009; Gamo and
Arnsten, 2011). Consequently, disruptions of NE signaling in
prefrontal cortex have been linked to the etiology of several
neuropsychiatric disorders such as major depression, attention-
deficit/hyperactivity disorder (ADHD), and AD (West et al., 2009;
Arnsten and Pliszka, 2011; Robertson, 2013). Traditionally, the
cortical NE system has been associated with basic functions such
as arousal and sleep-wake cycle (Jouvet, 1969; Aston-Jones et al.,
1999), but current perspectives suggest that NE has a key role
in signal detection and behavioral control (Sara, 2009), thus
optimizing task performance under impaired conditions (Aston-
Jones and Cohen, 2005). Specifically, NE is thought to exert an
inverted-U shaped dose effect on prefrontal cortex functioning,
such that intermediate signals are required for regular perfor-
mance and either too little (e.g., through depletion) or too much
(e.g., due to uncontrollable stress) NE activity impairs perfor-
mance (Greene et al., 2009). NE signaling in prefrontal cortex
has been implicated in fundamental cognitive functions (Berridge
and Waterhouse, 2003; Robbins and Arnsten, 2009), including
working memory and emotional learning (Chamberlain et al.,
2006), both of which are highly preserved across species and cru-
cial for survival. Substantial evidence for a central role of NE in
these memory functions comes from challenge studies in which
the α2-adrenergic agonist clonidine or the non-selective β1–3-
adrenergic antagonist propranolol modulated working memory
and emotional memory formation (Davis et al., 1979; Cahill et al.,
1994; Franowicz and Arnsten, 1999; Li et al., 1999; Strange and
Dolan, 2004; Hurlemann, 2008; Hurlemann et al., 2010; Tully
and Bolshakov, 2010). Given this intimate functional relationship,
and in view of evolutionary perspectives suggesting that survival
stress and malnutrition are the rule rather than the exception
in driving adaptation, the question emerges if there is evidence
for a neural compensation of transient fluctuations in NE sig-
naling. To address this question, we administered, in two sep-
arate double-blind, randomized, placebo-controlled functional
MRI (fMRI) experiments, a 40-mg single oral dose of propra-
nolol to healthy volunteers in order to disrupt noradrenergic
signaling via β-noradrenergic receptors. Specifically, the ratio-
nale was to induce a transient state of sub-optimal functioning
of NE-dependent cognitive operations in the domains of (i)
working memory and (ii) emotional memory formation. The
latter was assessed using a classical Pavlovian fear conditioning
paradigm. We hypothesized that our experimental intervention
would elicit compensatory neural responses in the absence of
behavioral performance deficits.
MATERIALS AND METHODS
EXPERIMENTAL DESIGN AND PROCEDURES
The rationale of this randomized, double-blind, placebo-
controlled trial was to challenge compensatory mechanisms that
enable the human brain to preserve cognitive functioning. In
independent experiments, two fundamental cognitive functions
vital for survival (Experiment 1, working memory; Experiment 2,
emotional learning) were challenged in young, healthy partici-
pants. In both experiments the centrally and peripherally acting
non-selective β-adrenergic antagonist propranolol (PRO) was
used to pharmacologically induce transient suboptimal nora-
drenergic functioning in young, healthy participants with a
presumably high compensatory potential. In view of the phar-
macokinetic profile of PRO (time to peak plasma concentration,
1–3 h; elimination half-life, 3–4 h), participants received either
PRO or lactose placebo (PLC) 120min before the start of each
experiment. We administered a 40-mg single oral dose of PRO in
accordance with our previous studies, which documented behav-
ioral and neural effects in healthy subjects (Hurlemann et al.,
2005, 2010; Onur et al., 2009). Blood pressure was measured
at the time of PRO/PLC administration as well as immediately
before and after the scanning session. Paired t-test comparisons
revealed a (trend to) significant decrease in systolic blood pressure
from baseline to pre fMRI measurement (Experiment 1 p = 0.11;
mean, s.e.m. at baseline, 121.42, 1.80; mean s.e.m. at pre-fMRI,
118.89, 1.61; Experiment 2 p = 0.07; mean, s.e.m. at baseline,
122.30, 2.55; mean s.e.m. at pre-fMRI, 118.76, 3.20) and from
baseline to post fMRI measurement (Experiment 1 p = 0.05;
mean s.e.m. at post-fMRI, 116.47, 2.34; Experiment 2 p = 0.03;
mean s.e.m. at post-fMRI, 119.07, 2.69) in the PRO group. No
significant change was observed in the PLC group (all p > 0.51).
Interindividual variation in the degree of first-pass metabolism
contributes to the differences in PRO plasma levels after oral
administration of equivalent doses (Wood et al., 1978). Therefore,
in Experiment 1 venous blood samples were collected immedi-
ately after scanning to determine the PRO plasma level in each
subject. PRO concentrations in serum specimens were quanti-
fied in the Medical Laboratory Bremen (http://www.mlhb.de)
using an LC-MS/MS approach. In brief, sera were deproteinized
with acetonitrile/methanol after addition of methylrisperidone as
the internal standard. Samples were then centrifuged and super-
natants were diluted with mobile phase (acetonitrile/acetic acid).
After separation from matrix components by HPLC (Agilent
1100C; Agilent Technologies, Santa Clara, CA), selected ion frag-
ments produced via electrospray ionization were detected and
quantified in a Sciex API4000 (Applied Biosystems, Carlsbad, CA)
triple-quadrupole mass spectrometer. Assays were calibrated with
spiked pool sera, the detection limit (signal/noise ratio = 3) was
1μg/L, and the imprecision (coefficient of variation) within series
(n = 10) amounted to 8.2%. Mean plasma concentrations were
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24.3 ± 9.52μg/L. To account for potential effects of medication
awareness participants were asked to rate whether they received
PRO or PLC at the end of Experiment 2. For a schematic syn-
opsis and experimental timelines of the experiments see Figure 1
(Experiment 1, Figure 1A; Experiment 2, Figure 1B).
PARTICIPANTS
For both experiments healthy, young right-handed volunteers
were recruited by advertisement and provided written informed
consent. All volunteers were free of current or past medical
(including respiratory or allergic illness), neurological, or psychi-
atric disorders as assessed by medical history and a structured
clinical interview for DSM-IV and ICD-10 psychiatric disor-
ders (Mini-International Neuropsychiatric Interview; M.I.N.I)
(Sheehan et al., 1998). Volunteers were naïve to prescription-
strength psychoactive medication [including propranolol for the
treatment of “exam nerves” (Brewer, 1972)] and had not taken
any over-the-counter psychoactive medication within the past
4 weeks. Tobacco smokers and volunteers with known con-
traindications for MRI scanning were excluded from partici-
pation. To control for pre-treatment differences in cognitive
performance, all volunteers were administered a comprehensive
neuropsychological test battery. Screening included the RAVLT
(Rey Auditory Verbal Learning Test) (Rey, 1941; Helmstaedter
et al., 2001) to assess verbal learning skills, the DST (digit-
span test) derived from the revised Wechsler adult intelligence
scale (Wechsler, 1997) to assess working memory, the LPS
4 (“Leistungspruefsystem Subtest 4”) (Horn, 1983) to assess
non-verbal reasoning IQ, the MWT-B (“Mehrfach-Wortschatz-
Intelligenztest Teil B”) (Lehrl, 1978) to assess verbal IQ based on
lexical decisions, and the trail-making test (TMT) part A and
B (Raitan, 1958) to assess visual attention and task-switching.
Handedness was determined by the Edinburgh handedness inven-
tory (EHI) (Oldfield, 1971). The study had full ethical approval
and was carried out in compliance with the latest revision of the
Declaration of Helsinki.
A total of 36 participants (18 females, mean age, 24.4 years; age
range 21–32 years) were enrolled in Experiment 1 and received
either a 40-mg single oral dose of PRO (n = 17; 7 females) or PLC
(n = 19; 11 females) before the they were administered the spatial
working memory task and the visual stimulation paradigm. The
treatment groups were of comparable age, gender distribution,
education, and pre-treatment neuropsychological performance
(all p-values > 0.05) (Table 1). For Experiment 2 30 partici-
pants were recruited (14 females, 25.1 years; age range 21–31
years) and received either a 40-mg single oral dose of PRO
(n = 15; 6 females) or PLC (n = 15; 8 females) before they were
administered the emotional learning paradigm. Due to technical
failures during data acquisition of the aversive learning paradigm
the data from 5 participants had to be excluded from further
analysis (PRO, n = 2; PLC, n = 3). The treatment groups (after
exclusion of the 5 participants, PRO, n = 13, 5 females; PLC,
n = 12, 6 females) were comparable in terms of age, gender
distribution, education, and pre-treatment neuropsychological
performance (Table 1). To control for confounding effects of PRO
on attention, subjects in both experiments completed the d2
test (“Aufmerksamkeits- und Belastungstest d2”) (Brickenkamp,
1995) immediately before scanning. Participants were instructed
to maintain their regular sleep and wake schedule and to abstain
from caffeine and alcohol intake on the day before scanning.
EXPERIMENTAL PARADIGMS
Experiment 1—spatial working memory paradigm
We administered an adapted version of an event-related visuospa-
tial delayed matching-to-sample working memory task (McNab
and Klingberg, 2008; Markett et al., 2010). Participants had to
remember a variable number of positions during a delay and
to compare a probe location with the sample stimulus locations
maintained in working memory. After a 500-ms fixation period,
a circular grid divided into 16 sections was presented for 1000ms
as the sample stimulus. In the grid one, three, or five red squares
appeared in random positions with the constraint that no more
than two squares were located in adjacent locations. After a reten-
tion interval of 2500ms the grid was presented again for 2000ms
with one position cued (probe). Participants had to indicate by
button press whether or not the location of the probe matched
FIGURE 1 | Experimental timelines and fMRI paradigms. Experimental
timeline of Experiment 1 (A) and Experiment 2 (B). In both experiments
volunteers were administered either placebo (PLC) or propranolol (PRO)
120min before testing. Blood pressure (BP) was measured at the time of
verum/placebo administration as well as immediately before and after the
scanning session. To control for confounding effects of propranolol on
attention all subjects completed the d2 test (“Aufmerksamkeits- und
Belastungstest d2”) (Brickenkamp, 1995) immediately before the scanning
session. In Experiment 1 venous blood samples were drawn for propranolol
plasma level analysis. In Experiment 2 participants were administered a
questionnaire to assess treatment awareness. Abbreviations: PLC, placebo;
PRO, propranolol; BP, blood pressure.
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Table 1 | Two-sample t-tests showed no significant pretreatment
differences in demographic and neuropsychological characteristics
between the placebo- and propranolol-treated groups (displayed are
mean and SD for both groups).
Experiment 1 Placebo (n = 19) Propranolol (n = 17)
Age, years 24.41 (±3.26) 25.76 (±3.08)
Education, years 16.50 (±2.13) 16.29 (±1.51)
Gender distribution (f:m) 10:7 8:11
RAVLT
Trial 1–5a 59.31 (±7.42) 58.47 (±7.42)
Trial 5b 13.15 (±2.05) 13.41 (±1.62)
Trial 6 Retentionc 12.73 (±2.40) 12.58 (±2.26)
Trial 7 Delayed Recalld 12.63 (±2.26) 13.05 (±2.26)
MWT-Be 30.89 (±2.20) 30.06 (±2.21)
TMT-Af 22.87 (±8.90) 24.81 (±6.32)
TMT-Bg 55.62 (±14.47) 67.31 (±21.95)
Digit-span, forwardh 8.36 (±1.64) 8.17 (± 2.27)
Digit-span, backwardsi 7.05 (±1.50) 7.76 (±2.35)
Experiment 2 Placebo (n = 12) Propranolol (n = 13)
Age, years 24.43 (±2.50) 24.25 (±3.23)
Education, years 16.50 (±2.12) 17.46 (±1.75)
Gender distribution (f:m) 6:6 8:5
RAVLT
Trial 1–5a 57.80 (±8.29) 60.23 (±9.05)
Trial 5b 13.41 (±1.67) 13.38 (±2.02)
Trial 6 Retentionc 12.50 (±2.31) 12.15 (±2.67)
Trial 7 Delayed Recalld 12.83 (±2.32) 12.69 (±2.46)
MWT-Be 30.00 (±3.90) 28.93 (±4.09)
TMT-Af 25.75 (±6.90) 26.81 (±8.32)
TMT-Bg 64.25 (±18.47) 60.31 (±16.95)
Digit-span, forwardh 7.83 (±2.37) 7.53 (± 1.54)
Digit-span, backwardsi 7.58 (±2.15) 7.69 (±2.56)
RAVLT, Rey Auditory Verbal Learning.
aLearning performance across five trials.
bSupraspan.
cSusceptibility to interference.
d Delayed recall after 30 min; MWT-B, Mehrfachwahl-Wortschatz-Intelligenz-Test.
eNumber of correct responses, TMT-A, TMT-B, Trail-Making Test A, B.
f , gProcessing time inseconds; DST, digit-span forward and backward test.
h, i Number of digits correctly recalled.
the position of one of the red squares of the sample stimulus
(left index finger: no match, right index finger: match). Working
memory load was manipulated by displaying 1, 3, or 5 red squares
during the sample period. Participants were instructed to respond
as fast as possible while avoiding errors. Forty trials per load con-
dition (one, three, and five positions), distributed across two runs,
were presented in randomized order in an event-related design.
Trial duration was 6000ms and the mean duration of the jit-
tered intertrial interval was 3720ms (2500–4500ms, in 500ms
steps). Each run had a mean duration of ∼7.5min; resulting
in a total duration of 15min. In total, 152 dynamic scans were
recorded per run, resulting in 254 dynamic scans for the entire
experiment.
Experiment 1—visual stimulation paradigm
We used a 10 × 10 checkerboard with green-to-red switches at a
frequency of 8 per second over a block with duration of 16 s. Six
blocks of checkerboard stimulation alternated with six blocks of
rest, at which a blank screen was presented.
Experiment 2—aversive learning paradigm
Pavlovian fear conditioning is highly conserved across species,
thus providing a powerful model to study compensatory mech-
anisms during emotional memory formation.
Stimuli. The unconditioned stimulus (UCS) consisted of brief
electrical shocks of 2ms duration. The electrical shock stimuli
were delivered via a SHK1 aversive shock stimulator (Contact
Precision Instruments, Cambridge,MA) coupled with a notebook
computer. Current was passed from the generator to the subject
via two Ag/AgCl electrodes filled with electrolyte gel on the sub-
ject’s left (non-dominant) dorsal lower arm. Before acquisition,
shock intensity levels were set manually for each individual by
delivering gradually more intense shocks (0–5mA range) until
the subject reported the shock was “highly annoying yet not
painful.” The two conditioned stimuli (CS+, which was paired
with the UCS in 75% contingency that coterminated with the
CS+, and CS−, which was never paired with the UCS) con-
sisted of one male and one female face from the Ekman series
(Ekman and Friesen, 1971) whose hair was removed. Mildly
(20%) angry faces were chosen on previous studies showing suc-
cessful conditioning with mildly angry faces (Critchley et al.,
2002; Kalisch et al., 2006). The two same faces were used for
all subjects, CS+ and CS− assignment to the male and female
face was balanced across treatment and gender of the partici-
pants. During the conditioning procedure the skin conductance
responses (SCRs) were sampled simultaneously with MR scans.
SCRs were acquired at a sampling rate of 1000Hz from Ag/AgCl
electrodes filled with isotonic electrolyte gel on the middle and
ring finger of the left (non-dominant) hand by means of a SC5
24-bit Skin Conductance System (Contact Precision Instruments,
Cambridge, MA).
Instruction. Subjects were told the intention to study face pro-
cessing under stress and were debriefed at the end of the study.
To ensure attentional processing of the stimuli the subjects per-
formed an unspeeded gender decision task with the index finger
(male) and thumb (female) of their dominant (right) hand.
Conditioning procedure. Subjects were first habituated to the
CSs by presenting each CS five times before the conditioning
procedure. Throughout the acquisition procedure the CS+ and
CS− were presented 38 times for 6000ms in a randomized order
(restriction: no more than two consecutive presentations of one
CS). The CS+ was followed by shock in 75% contingency. CSs
were separated by a variable interstimulus interval (ISI) ranging
from 8 to 11 s, during which subject viewed a central fixation
cross (low-level baseline). Following the acquisition phase, con-
tingency was measured via a questionnaire asking participants
whether they had noticed any relationship between the shock and
the gender of the face.
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MRI data acquisition. For MRI acquisition a 1.5 Tesla Siemens
Avanto MRI system (Siemens, Erlangen, Germany) was used.
Task-related fMRI data were acquired using a T2∗-weighted echo-
planar EPI sequence (imaging parameters: TR = 3000ms, TE =
50ms, matrix size: 64 × 64, pixel size: 3 × 3 × 3mm, slice thick-
ness = 3.0mm, distance factor = 10%, FoV = 210, flip angle =
90◦, 35 axial slices). In addition, high-resolution anatomical
images were acquired on the same scanner using a T1-weighted
3D MPRAGE sequence (imaging parameters: TR = 1660ms,
TE = 3.09, matrix size 256 × 256, pixel size 1 × 1mm2, slice
thickness = 1.0mm, FoV = 256, flip angle = 15◦, 160 sagittal
slices).
fMRI DATA ANALYSIS
Preprocessing
Task-related fMRI data were preprocessed and analyzed using
SPM8 software (Wellcome Trust Centre for Neuroimaging,
London, United Kingdom; http://www.fil.ion.ucl.ac.uk/spm)
implemented in Matlab 7 (The MathWorks Inc., Natick, MA).
The first five volumes of each functional time series were dis-
carded to allow for T1 equilibration. Images were corrected
for head movement between scans by an affine registration
(Ashburner and Friston, 2003). For realignment, a two-pass pro-
cedure was used, by which images were initially realigned to
the first image of the time-series and subsequently re-realigned
to the mean of all images. For spatial normalization, the mean
EPI image of each subject was normalized to the current
Montreal Neurological Institute (MNI) template (Evans et al.,
1992; Holmes et al., 1998) using the unified segmentation func-
tion implemented in SPM8. This algorithm combines image
registration, tissue classification, and bias correction within the
same generative model. All images were hereby transformed into
standard stereotaxic space and resampled at 3 × 3 × 3mm voxel
size. The normalized images were spatially smoothed using an
8-mm FWHM Gaussian kernel. Raw time series were detrended
by the application of a high-pass filter (cut-off period, 128 s).
Working memory paradigm
Separate onset regressors for the three levels of WM load were
modeled by a stick function convolved with a hemodynamic
response function (Friston et al., 1994). The movement param-
eters were included as confounds. Specific effects were assessed by
contrasting the load 5 and load 3 conditions with the load 1 con-
dition, which served as a baseline due to its negligible engagement
of working memory resources. Effects of treatment were analyzed
by directly comparing the PRO and the PLC treatment group by
means of t-tests entering the contrasts “load 3> load 1” and “load
5> load 1.”
Visual stimulation paradigm
The visual stimulation was modeled by a boxcar function con-
volved with a canonical hemodynamic response function. The
design matrix comprised contrasts of alternating intervals of
visual stimulation and rest, the time derivative, and the six head
movement parameters as confounds. Specific effects were assessed
by contrasting the visual stimulation condition with the rest con-
dition. Effects of treatment were analyzed by directly comparing
the PRO- and the PLC-treated groups using a two-sample
t-test.
Emotional learning paradigm
Separate onset regressors for the CS+, CS−, and the UCS were
modeled by a stick function convolved with a hemodynamic
response function (Friston et al., 1994). The movement parame-
ters were included as confounds. Specific effects of the condition-
ing procedure in the entire sample were assessed by contrasting
the CS+ with the CS−. We used structurally defined regions of
interest to enhance the statistical power in regions that have con-
sistently been implicated in fear-conditioning [systematic review
in (Sehlmeyer et al., 2009)]: amygdala, insula and anterior cin-
gulate cortex. Effects of treatment were analyzed by directly
comparing the PRO and the PLC treatment group by means a
t-test entering the contrast “CS+ > CS−.”
ROI definition
Previous literature indicates consistently greater, and presum-
ably compensatory, activity in ventrolateral PFC (vlPFC) and
dorsolateral PFC (dlPFC) regions among patient populations
(Maruishi et al., 2007; Schwindt and Black, 2009; Smith et al.,
2010). Based on these results, the analysis of effects of subop-
timal noradrenergic functioning was focused on these regions.
Regions-of-interest (ROIs) were anatomically defined using the
WFU Pickatlas (Version 3.0), which provides a method for gen-
erating ROI masks based on the Talairach Daemon database
(Tzourio-Mazoyer et al., 2002; Maldjian et al., 2003, 2004). The
inferior frontal gyrus (IFG) served as the ROI for the vlPFC
and Brodmann area (BA) 9 served as the dlPFC ROI. ROI-
based two-sample t-tests were computed with a threshold of
p < 0.05 and Family-Wise Error (FWE) corrected for multiple
comparisons.
SKIN CONDUCTANCE DATA ANALYSIS
Skin conductance data were downsampled to 100Hz and visu-
ally inspected for artifacts. Data from the first 5 subjects had to
be discarded due to severe artifacts in the MRI and SCR data
(PRO, n = 2; PLC, n = 3). After installing custom-made filters
between the MRI control room and the scanner room artifacts
could be controlled for the subsequently scanned subjects. All
subsequent analyses of the emotional learning data were there-
fore performed using the data acquired from 25 subjects (PRO,
n = 13, 5 females; PLC, n = 12, 6 females). In line with previ-
ous investigations an SCR was defined as the maximum of the
SCR signal in the time window of 4.8 s after CS onset minus an
SCR baseline value (the mean of the SCR in the second before the
onset of the SCR) (Buchel et al., 1998; Kalisch et al., 2006). To
account for interindividual differences in physiological reactivity,
SCR data were z-transformed (Buchel et al., 1998). Significance
of SCR difference between CS− and CS+ was assessed using a
Two-Way repeated measures ANOVA with treatment (PLC vs.
PRO) as between-subject factor and stimulus type (CS+ vs. CS−)
as within-subject factor. Based on the previous literature that
allowed a directed hypotheses for the effects of conditioning
(CS+ > CS−), a one-tailed threshold of p = 0.05 was used for
the SCR data.
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RESULTS
EXPERIMENT 1
Behavioral data (working memory performance)
Analysis of the attentional performance data acquired immedi-
ately before scanning revealed no significant performance differ-
ences between the PLC- and PRO-treated subjects [t(34) = 0.39,
p = 0.69]. This indicates that effects of a β-adrenergic blockade
on working memory are not confounded by reduced attentional
capacities. Analysis of working memory accuracy (percent cor-
rect responses), using a Two-Way repeated measures ANOVA
with treatment (PLC vs. PRO) as between-subject factor and
working memory load (load 1, load 3, and load 5) as within-
subject factor, revealed a significant main effect of working mem-
ory load [F(2, 33) = 200.42, p < 0.001]. Post-hoc analyses using
paired t-tests revealed that subjects displayed a gradual decrease
in percent correct responses from load 1 (96.8 ± 4.3%) over load
2 (84.9 ± 8.4%) to load 3 (70.1 ± 9.3%) with significant perfor-
mance differences between load 3 and load 2 [t(35) = 11.9, p <
0.001] and load 2 and load 1 [t(35) = 9.1, p < 0.001]. This con-
firms an increase in working memory demands across the three
load conditions. Neither the main effect of treatment [F(1, 34) =
0.123, p > 0.05] nor the treatment × load interaction effect
[F(2, 33) = 0.158, p > 0.05] reached statistical significance, indi-
cating that PRO had neither a general nor load-specific effect
on working memory accuracy (Figure 2A). The analysis of the
response latencies for correct responses using a Two-Way repeated
ANOVA revealed a significant main effect of working memory
load [F(2, 33) = 58.41, p > 0.001], thereby confirming increas-
ing task difficulty across the three load conditions. In addition,
there was a trend to significantmain effect of treatment [F(1, 33) =
3.46, p > 0.05], indicating shorter response latencies in the PRO-
treated subjects. However, the treatment × load interaction effect
failed to reach statistical significance [F(2, 33) = 3.46, p > 0.05],
indicating that there was no load-specific effect of PRO (Table 2;
Figure 2B).
FMRI data—working memory
In line with previous fMRI studies using spatial working mem-
ory paradigms (Wager and Smith, 2003; Rottschy et al., 2012)
we found increased activity in the fronto-parietal working mem-
ory networks for both working memory contrasts (“load 3 >
load 1”; “load 5 > load 1”) (see also Table 3 for the main
effect ofWM load). Anatomically restricted comparisons between
the treatment groups revealed significantly increased activity in
the pars triangularis subdivision of the left IFG of the PRO-
treated subjects for the contrast “load 5 > load 1” [t(34) = 6.87;
p < 0.05, FWE-corrected; maximum t-value located in MNI-
space at x = −33, y = 35, z = −2] (Figure 3A). There were no
significant differences in the opposite direction or for the con-
trast “load 3 > load 1.” An exploratory whole-brain analysis
revealed that the effect in the left IFG remained significant on
the whole-brain level. In addition, this analysis revealed no other
regions with significant between-group differences, indicating
regional-specific effects. For illustration purposes the individual
parameter estimates were extracted from a sphere (6mm radius)
centered at the coordinates of the maximum t-value (Figure 3A).
To explore associations between WM performance and IFG
activity bivariate correlations (Pearson) between the behavioral
performancemeasures (percent correct responses, response laten-
cies) and the extracted IFG parameter, estimates were computed
within each group. However, this analysis revealed no significant
results (results are given in Table 4). Taken together, results from
Experiment 1 indicate that PRO had no effects on working mem-
ory performance but concomitantly increased activity in the pars
triangularis subdivision of the left IFG under conditions of high
working memory load.
Table 2 | Behavioral results from the working memory task.
Placebo
(n = 19)
Propranolol
(n = 17)
LOAD 1
Response accuracy (percent correct)
Response latencies (in ms)
96.85 (0.70)
796 (25)
96.75 (1.31)
711 (29)
LOAD 2
Response accuracy (percent correct)
Response latencies (in ms)
83.17 (2.02)
981 (23)
86.72 (1.89)
930 (38)
LOAD 3
Response accuracy (percent correct)
Response latencies (in ms)
70.68 (2.38)
1115 (36)
69.38 (1.99)
974 (78)
Mean values and s.e.m. are displayed.
FIGURE 2 | Behavioral data. Placebo- and propranolol-treated subjects did
not differ in (A) working memory accuracy and (B) response latencies
(∗p < 0.05, two-tailed). (C) Larger SCRs during CS+ vs. CS− throughout the
conditioning procedure suggests successful conditioning. Z scores were
used instead of raw values (microSiemens) to account for interindividual
differences. (∗p < 0.05, one-tailed). Displayed are group-mean values and
corresponding standard errors of the mean (s.e.m.). Abbreviations: PLC,
placebo; PRO, propranolol.
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FMRI data—visual stimulation
Analysis of the whole sample indicated that the checkerboard
stimulation paradigm elicited robust neural responses in the
bilateral visual cortex. Direct comparison of the PRO- and PLC-
treated groups revealed no significant differential activations,
arguing against non-specific treatment effects possibly result-
ing from globally decreased noradrenergic receptor activity or
homogenous changes in cerebral hemodynamics.
EXPERIMENT 2
Behavioral data (treatment and contingency awareness)
In the post-scan questionnaire 5 (PLC, n = 3; PRO, n = 2) par-
ticipants answered that they could not rate whether they received
PRO or PLC. From the remaining participants (PLC, n = 9;
PRO, n = 11) 4 in the PLC and 5 in the PRO group correctly
identified their treatment. A Chi2-test confirmed that the cor-
rect identification in both groups was not greater than chance
(Chi21 = 0.20, p > 0.05). Of the 25 subjects 20 (PLC, n = 10;
PRO, n = 10) reported awareness of the CS+—UCS contingency
Table 3 | Significant main effect of working memory load (“load 3 +
load 5 > load 1”) in the entire sample (n = 36) thresholded at
p > 0.05 (FWE-corrected).
Region Number of MNI-coordinates Maximum
voxels (x/y/z) t-value
Insula R 279 33/23/−2 11.80
Insula L 446 −33/23/−5 11.55
Middle occipital gyrus R 481 39/−76/34 10.09
Postcentral gyrus L 637 −51/−34/55 9.81
Inferior frontal gyrus R 337 48/35/25 9.43
Middle frontal gyrus L 102 −33/53/16 9.21
Superior frontal gyrus 235 0/29/37 9.11
Thalamus L 87 −12/−4/10 8.87
Precuneus L 390 −6/−70/52 8.77
Culmen R 32 3/−52/−8 8.64
Inferior temporal gyrus R 22 51/−52/−5 7.78
Rolandic Operculum R 51 48/−19/19 7.09
in the post-scan questionnaire. All participants performed the
gender decision task with a high degree of accuracy (percent cor-
rect responses: PLC, CS+, 98.7 ± 2.1%; CS−, 98.5 ± 2.0%; PRO,
CS+, 98.6 ± 2.0%; CS−, 99.1 ± 1.7%).
Skin conductance data (emotional learning)
Visual inspection of the SCR data indicated that 8 participants
(PLC, n = 3; PRO, n = 5) did not show any apparent SCR to the
UCS and therefore were excluded from further analysis. Mean
standardized SCRs from the remaining subjects were subjected
to a repeated measures ANOVA with the between subject fac-
tor treatment (PLC vs. PRO) and the within subject factor CS
type (CS+ vs. CS−). Results from an analysis including CS+—
UCS contingency aware participants (PLC, n = 8; PRO, n = 6)
confirmed successful conditioning by a significant main effect
of CS type [F(1, 12) = 5.47, p < 0.05, one-tailed; post hoc paired
t-test, t(13) = 2.44, p < 0.05, one-tailed; mean z-value, s.e.m.;
CS+, 0.099, 0.04; CS−, −0.099, 0.04]. However, neither the
main effect of treatment [F(1, 12) = 0.13 p > 0.05] nor the treat-
ment × CS type interaction effect reached statistical significance
[F(2, 12) = 0.02, p > 0.05]. (the corresponding data are pre-
sented in Table 5, Figure 2C). Together these results suggest that
beta-noradrenergic blockade did not interfere with contingency
Table 4 | Bivariate correlations between the extracted parameter
estimates from the left inferior frontal gyrus and working memory
performance.
Placebo
(n = 19)
Propranolol
(n = 17)
LOAD 1
IFG activity—response accuracy
IFG activity—response latencies
−0.25 (p = 0.30)
0.12 (p = 0.64)
0.14 (p = 0.60)
−0.08 (p = 0.78)
LOAD 2
IFG activity—response accuracy
IFG activity—response latencies
0.17 (p = 0.33)
−0.14 (p = 0.57)
−0.02 (p = 0.95)
0.05 (p = 0.85)
LOAD 3
IFG activity—response accuracy
IFG activity—response latencies
0.38 (p = 0.11)
−0.15 (p = 0.55)
0.18 (p = 0.48)
−0.04 (p = 0.90)
FIGURE 3 | fMRI results. (A) Experiment 1. During high working memory
load propranolol-treated subjects showed stronger activity in the left inferior
frontal gyrus (IFG). Plotting the individual extracted parameter estimates for
the left IFG revealed that activity in this region increased with working
memory load after propranolol, yet not placebo treatment. (B) Experiment 2.
During emotional memory acquisition propranolol-treated subjects showed
stronger activity in the right IFG. Plotting the individual extracted parameter
estimates for the right IFG revealed this effect was driven by selective effects
of propranolol on the CS+. Abbreviations: PLC, placebo; PRO, propranolol;
IFG, inferior frontal gyrus; CS+, conditioned stimulus.
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awareness or the acquisition of conditioned autonomic responses
during the conditioning procedure.
FMRI data—emotional learning
In line with previous fMRI studies using aversive condition-
ing procedures (Sehlmeyer et al., 2009) we found that the CS+
resulted in stronger BOLD responses than the CS− in the bilateral
anterior cingulate (ACC) [left ACC, t(24) = 4.32, MNI coor-
dinates x = −4, y = 32, z = 22; right ACC, t(24) = 4.46, MNI
coordinates x = 2, y = 22, z = 26; p < 0.05; FWE-corrected]
and the bilateral insula (INS) [left INS, t(24) = 4.41, MNI coor-
dinates x = −30, y = 20, z = 8; right INS, t(24) = 5.17, MNI
coordinates x = 36, y = 20, z = 8; p < 0.05; FWE-corrected] in
the entire sample (see Table 6). Anatomically restricted compar-
isons between the CS+-UCS contingency aware participants in
the treatment groups (PLC, n = 10; PRO, n = 10) revealed sig-
nificantly increased activity in the pars triangularis subdivision
of the right IFG of the PRO-treated subjects for the contrast
“CS+ > CS−” [t(18) = 6.42; p < 0.05, FWE-corrected; maxi-
mum t-value located in MNI-space at x = 50, y = 32, z = 28]
(Figure 3B). Findings remained significant when all participants
were included [PRO, n = 13; PLC, n = 12; t(23) = 5.34; p <
0.05, FWE-corrected; maximum t-value located in MNI-space
at x = 50, y = 32, z = 28]. An exploratory whole-brain analysis
for the entire sample revealed no other regions with signifi-
cant between-group differences. However, the effect in the right
IFG also failed to reach statistical significance on the whole-
brain level. Subsequently extracted individual parameter esti-
mates from a 6mm radius sphere centered at the coordinates
of the maximum t-value from the between group comparison,
revealed, that PRO selectively increased activity for the CS+
(Figure 3B, group differences for both tasks are summarized
in Table 7).
Table 5 | SCR responses from the emotional learning task.
Placebo
(n = 8)
Propranolol
(n = 6)
SCR RESPONSE (z-VALUES)
CS+
CS−
CS+ >
CS−
0.09 (0.07)
−0.09 (0.07)
0.19 (0.15)
0.11 (0.01)
−0.11 (0.02)
−0.21 (0.03)
Mean z-standardized SCR responses and s.e.m. are displayed.
Table 6 | Significant main effect of stimulus type (“CS+ > CS−”) in
the entire sample (n = 25) thresholded at p > 0.05 (FWE-corrected for
the size of the ROI).
Region of Maximum MNI-coordinates
Interest (ROI) t-value (x/y/z)
Insula R 5.17 −36/20/8
Insula L 4.41 30/20/8
Anterior cingulate cortex R 4.46 2/22/26
Anterior cingulate cortex L 5.39 −4/32/22
DISCUSSION
The hypothesis of neural compensation has been widely used
to explain a pattern of intact cognitive performance and con-
comitantly increased activity in neuropsychiatric populations.
In the present randomized, double-blind, placebo-controlled
pharmacological fMRI study the β-receptor antagonist propra-
nolol was used to model conditions of (transient) suboptimal
noradrenergic functioning in healthy young subjects perform-
ing working memory (Experiment 1) and emotional learning
(Experiment 2) tasks. Consistent with our initial hypothesis,
β-receptor blockade with propranolol did not influence, or inter-
fere with, workingmemory or emotional learning performance in
healthy young subjects. Indeed, both cognitive functions showed
a high resistance against transient variation in NE signaling. Of
note, across both experiments the lack of performance decre-
ments was accompanied by increased activity in the IFG during
cognitive challenge.
Before an in depth discussion of the present findings limi-
tations of the present experimental approach need to be con-
sidered. In the present study we used pharmacological fMRI
as an innovative approach to elicit neural compensation in the
healthy brain. However, one constraint of the fMRI methodol-
ogy is it does not allow causal brain-behavior relations to be
drawn. Conclusions regarding the functional relevance of the
increased activity observed during the present study thus must
remain preliminary. One possible way to address this issue in
future studies could be the use of different doses of propra-
nolol. Using increasing doses of propranolol should ultimately
lead to compensatory failure and apparent behavioral impair-
ments. Conversely, propranolol in higher doses has been shown
to affect downstream cognitive domains. Particularly confound-
ing effects of β-receptor blockade on attention (Aston-Jones et al.,
1999; De Martino et al., 2008) might certainly influence, and
interfere with processes in higher-order cognitive domains. In
addition, increasing doses of propranolol produce significant
decreases in heart rate and blood pressure (Campbell et al., 2008;
de Rover et al., 2012). In fMRI experiments these cardiac-related
effects can lead to global susceptibility effects caused by pul-
satile motion of the brain as well as local blood pressure-related
changes in the BOLD signal (Hagberg et al., 2008). Another pos-
sible way to examine the functional relevance of the increased
PFC activity could be the use of non-invasive brain stimula-
tion techniques. For instance, repetitive transcranial magnetic
Table 7 | Significant between-group differences from both
experiments thresholded at p > 0.05 (FWE-corrected for the size of
the ROI).
Paradigm Region of
Interest (ROI)
MNI-coordinates
(x/y/z)
Maximum
t-value
Working memory
PRO > PLC (“load
5 > load 1”)
Inferior frontal
gyrus L
−33/35/−2 6.87
Emotional memory
PRO > PLC (“CS+
> CS−”)
Inferior frontal
gyrus R
50/32/28 5.34
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stimulation (rTMS) has been used successfully to disturb cog-
nitive performance by discharging neurons located in the cortex
(Walsh and Pascual-Leone, 2003) and is thus ideally suited to dis-
rupt putative compensatory activity in the IFG. Given that the
increased activity is engaged in the functional compensation its
disruption by rTMS should lead to a failure of compensation
and unmask performance impairments. Still, our data provide
evidence for the functional relevance of the observed response
increases in the IFG. First, propranolol selectively increased activ-
ity and connectivity under conditions of cognitive challenge (high
working memory load, CS+) but had no effect during the con-
trol conditions (attentional control condition, CS−). Second, in
accordance with a putative compensatory increase, activity and
connectivity of the prefrontal cortex regions increased with work-
ing memory load. Consistent with the compensatory hypoth-
esis, these findings indicate that neural effects of suboptimal
NE signaling were specifically associated to, and increased with,
cognitive load.
The observed lack of behavioral effects of a 40-mg single
dose of propranolol on working memory and emotional memory
seems contradictory to previous findings. However, behavioral
studies in healthy volunteers that used comparable single-dose
application schemes yielded inconsistent effects of propranolol on
working memory performance. Muller and colleagues reported
decreased working memory performance in healthy young vol-
unteers following a 25-mg single-dose application of propra-
nolol (Muller et al., 2005). While, others found no (Alexander
et al., 2007) or even beneficial effects of a 40-mg propranolol
dose on working memory performance (Campbell et al., 2008).
Differencesmight be explained by the inverted U shaped effect NE
has on cognitive performance. Different cognitive functions have
distinct levels of optimal noradrenergic activity (Robbins, 2000)
and consequently show different sensitivities for beta-adrenergic
blockade. Negative effects on working memory performance were
specifically observed during the manipulation of information
maintained in working memory (Muller et al., 2005). In con-
trast, the working memory task administered in the present
study required short-term maintenance only. Unexpectedly, we
observed a trend for shorter response latencies in the propranolol-
treated subjects. This effect might reflect the beneficial effects
of beta-adrenergic antagonists under conditions of psychological
stress (Ramos et al., 2005; Alexander et al., 2007). Effects of pro-
pranolol on emotional memory encoding in healthy volunteers
have been extensively studied. The majority of studies used emo-
tional stimuli (e.g., emotional slides or words) and found reduced
recall for emotionally salient material (overview by Chamberlain
and Robbins, 2013). Effects of propranolol on the acquisition of
fear conditioning in humans have been studied by Grillon et al.
(2004) who, in line with the present findings, did not observe
strong effects on cued fear conditioning. Compared with simple
maintenance or fear conditioning, the manipulation of working
memory content or the encoding of emotional slides involvemore
complex cognitive operations, which might render these behav-
ioral paradigms more susceptible to the effects of beta-adrenergic
blockade. In addition, previous studies observing no effects on
simple short-term maintenance or the acquisition of cued fear
responses (Grillon et al., 2004; Alexander et al., 2007) assessed
only behavioral effects, thus potential compensatory mechanisms
on the neural level cannot be excluded.
Across both experiments propranolol consistently increased
activity in the pars triangularis subdivision of the IFG (albeit
on contralateral sides) under cognitive challenge. Consistent with
several functional imaging studies in neuropsychiatric patients
our current data thus suggest a crucial role of the IFG in main-
taining cognitive performance under conditions of suboptimal
NE signaling. Meta-analytic data from fMRI studies on episodic
memory in AD patients revealed consistently increased IFG activ-
ity among these patients (Schwindt and Black, 2009). Support for
the functional relevance of IFG activity increases in AD patients
comes from two studies in which IFG activity predicted bet-
ter cognitive status (Diamond et al., 2007) and retrieval success
(Grady et al., 2003) among AD patients. Importantly, studies in
cognitively intact adults at genetic risk for AD have provided
further support for a specific involvement of the IFG in com-
pensatory mechanisms (Wishart et al., 2006; Filbey et al., 2010).
Moreover, our current results extend these previous findings in
neuropsychiatric populations and suggest that the IFG is not only
involved in the adaptation to slow progressing neuropathological
changes, but also supports compensation of transient fluctuations
in NE signaling. Considerable evidence suggests that the IFG is
critically implicated in the flexible adjustment of cognitive con-
trol, particularly through cognitive inhibition (Rubia et al., 2003;
Aron et al., 2004). Cognitive control refers to the ability to per-
form task-relevant cognitive operations in the face of interference
(Badre andWagner, 2007; Levy andWagner, 2011). More recently
the IFG has been implicated in a superordinate domain-general
cognitive control network that supports different executive func-
tions, including flexibility, workingmemory, and inhibition (Cole
and Schneider, 2007; Niendam et al., 2012). Therefore, the present
pattern of increased IFG activity during cognitive challenge may
indicate that propranolol-treated subjects achieved normal per-
formance through increasing cognitive control demands. This
interpretation would be in accord with the widely accepted role
of NE signaling in optimizing behavioral performance and in
improving signal-to-noise ratio (Arnsten et al., 1996; Aston-Jones
and Cohen, 2005).
Although propranolol produced increased IFG activity across
both tasks, the observed increases showed a task-specific laterality.
Differences in laterality might be related to the cognitive domain
that was challenged. Cognitive control refers to the ability to per-
form task-relevant cognitive operations in the face of interference
and considerable evidence has associated the bilateral IFG with
this function (Badre and Wagner, 2007; Levy and Wagner, 2011).
Some, however, not all, studies reported that the left and right IFG
may sub-serve specific sub-processes of cognitive control. The left
IFG in particular has been associated with interference reduction
during the maintenance phase of working memory processing.
This region has shown increased activity under conditions of high
interference in the Sternberg working memory task as compared
to a low-interference condition of the same task (Jonides et al.,
1998). In another study, left IFG responses were correlated with
the ability to resolve interference efficiently during workingmem-
ory processes (Bunge et al., 2001). In contrast, the contralateral
(right) IFG has been suggested to respond to currently relevant
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and salient stimuli to guide attention (Hampshire et al., 2010).
In line with this proposed function right IFG activity has repeat-
edly been observed when pre-learnt objects are detected (Linden
et al., 1999; Hampshire et al., 2007). Greater IFG activity in
propranolol-treated subjects in both tasks may therefore reflect
greater effort to remain focused on the salient stimuli and fil-
ter out distracting information. This interpretation would be in
accord with the widely accepted role of LC-NE signaling in opti-
mizing behavioral performance and in improving signal-to-noise
ratio (Arnsten et al., 1996; Aston-Jones and Cohen, 2005).
A potential constraint of the present study is the lack of
propranolol-induced decreased activity often observed in AD
patients and other neuropsychiatric populations. However, stud-
ies with cognitively intact adults at high risk for AD display
increased prefrontal activity during workingmemory without any
regions showing decreased activity (Wishart et al., 2006; Bokde
et al., 2010; Lancaster et al., 2011; Chen et al., 2013).
In conclusion, the present finding that suboptimal
β-adrenergic signaling did not disrupt performance in the
context of concomitantly increased IFG activity is consistent with
the pattern widely explained by the compensatory hypothesis.
Our findings thus suggest that (i) increasing activity may repre-
sent a common brain mechanism to maintain performance and
(ii) that regions within the cognitive control network, particularly
the IFG, are involved in compensatory mechanisms.
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